Cysteine is the main precursor of sulfur‐containing biological molecules in bacteria and contributes to the control of the cell redox state. Hence, this amino acid plays an essential role in microbial survival and pathogenicity and the reductive sulfate assimilation pathway is considered a promising target for the development of new antibacterials. Serine acetyltransferase (SAT) and O‐ acetylserine sulfhydrylase (OASS‐A), the enzymes catalyzing the last two steps of cysteine biosynthesis, engage in the formation of the cysteine synthase (CS) complex. The interaction between SAT and OASS‐A finely tunes cysteine homeostasis, and the development of inhibitors targeting either protein–protein interaction or the single enzymes represents an attractive strategy to undermine bacterial viability. Given the peculiar mode of interaction between SAT and OASS‐A, which exploits the insertion of SAT C‐terminal sequence into OASS‐A active site, we tested whether a recently developed competitive inhibitor of OASS‐A exhibited any effect on the CS stability. Through surface plasmon resonance spectroscopy, we (i) determined the equilibrium constant for the Salmonella Typhimurium CS complex formation and (ii) demonstrated that the inhibitor targeting OASS‐A active site affects CS complex formation. For comparison, the Escherichia coli CS complex was also investigated, with the aim of testing the potential broad‐spectrum activity of the candidate antimicrobial compound.
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex / Marchetti, M.; De Angelis, F. S.; Annunziato, G.; Costantino, G.; Pieroni, M.; Ronda, L.; Mozzarelli, A.; Campanini, B.; Cannistraro, S.; Bizzarri, A. R.; Bettati, S.. - In: CATALYSTS. - ISSN 2073-4344. - 11:6(2021). [10.3390/catal11060700]
|Appare nelle tipologie:||1.1 Articolo su rivista|